Contineum Therapeutics, Inc. — All Filings
147 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-3
S-8
SC 13G
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| S-8 | S-8 | 0001628280-26-015215 | Mar 5, 2026 | — |
| 424B5 | 424B5 | 0001628280-26-015205 | Mar 5, 2026 | — |
| 10-K | 10-K | 0001628280-26-015165 | Mar 5, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001628280-26-015159 | Mar 5, 2026 | — |
| 4 | FORM 4 | 0001437749-26-006422 | Mar 2, 2026 | — |
| 4 | FORM 4 | 0001437749-26-006421 | Mar 2, 2026 | — |
| 4 | FORM 4 | 0001437749-26-005892 | Feb 26, 2026 | Feb 24, 2026 |
| 4 | FORM 4 | 0001437749-26-005889 | Feb 26, 2026 | Feb 24, 2026 |
| 4 | FORM 4 | 0001437749-26-004912 | Feb 20, 2026 | Feb 19, 2026 |
| SCHEDULE 13G/A | — | 0001346824-26-000037 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0001193125-26-052863 | Feb 17, 2026 | — |
| 4 | FORM 4 | 0001437749-26-004126 | Feb 13, 2026 | Feb 11, 2026 |
| 4 | FORM 4 | 0001437749-26-004122 | Feb 13, 2026 | Feb 11, 2026 |
| 144 | — | 0001950047-26-001158 | Feb 11, 2026 | — |
| 144 | — | 0001950047-26-001156 | Feb 11, 2026 | — |
| 4 | FORM 4 | 0001437749-26-003212 | Feb 5, 2026 | Feb 3, 2026 |
| 144 | — | 0001950047-26-000891 | Feb 3, 2026 | — |
| 4 | FORM 4 | 0001437749-26-002579 | Jan 30, 2026 | — |
| 4 | FORM 4 | 0001437749-26-002578 | Jan 30, 2026 | — |
| 4 | FORM 4 | 0001437749-26-002577 | Jan 30, 2026 | — |
| 4 | FORM 4 | 0001437749-26-002576 | Jan 30, 2026 | — |
| 4 | FORM 4 | 0001437749-26-002575 | Jan 30, 2026 | Jan 28, 2026 |
| 8-K | FORM 8-K | 0001437749-26-002072 | Jan 26, 2026 | Jan 23, 2026 |
| 4 | FORM 4 | 0001437749-26-000616 | Jan 6, 2026 | Jan 5, 2026 |
| 144 | — | 0001950047-26-000145 | Jan 5, 2026 | — |
| 4 | FORM 4 | 0001437749-25-038938 | Dec 30, 2025 | Dec 29, 2025 |
| 4 | FORM 4 | 0001437749-25-038936 | Dec 30, 2025 | Dec 23, 2025 |
| 144 | — | 0001950047-25-010732 | Dec 29, 2025 | — |
| 144 | — | 0001950047-25-010672 | Dec 23, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-037842 | Dec 15, 2025 | Dec 11, 2025 |
| 424B5 | FORM 424B5 | 0001437749-25-037749 | Dec 12, 2025 | — |
| 424B5 | FORM 424B5 | 0001437749-25-037553 | Dec 11, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-037547 | Dec 11, 2025 | Dec 8, 2025 |
| 8-K | FORM 8-K | 0001437749-25-035860 | Nov 20, 2025 | — |
| 10-Q | FORM 10-Q | 0001437749-25-032427 | Oct 30, 2025 | Sep 30, 2025 |
| 8-K | FORM 8-K | 0001437749-25-032422 | Oct 30, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-029349 | Sep 18, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-108947 | Aug 14, 2025 | — |
| 10-Q | FORM 10-Q | 0001437749-25-024852 | Aug 5, 2025 | Jun 30, 2025 |
| 8-K | FORM 8-K | 0001437749-25-024849 | Aug 5, 2025 | — |
| SCHEDULE 13G | — | 0001415889-25-020291 | Jul 25, 2025 | — |
| 4 | FORM 4 | 0001437749-25-021373 | Jun 26, 2025 | — |
| 4 | FORM 4 | 0001437749-25-021372 | Jun 26, 2025 | — |
| 4 | FORM 4 | 0001437749-25-021371 | Jun 26, 2025 | — |
| 4 | FORM 4 | 0001437749-25-021369 | Jun 26, 2025 | — |
| 4 | FORM 4 | 0001437749-25-021367 | Jun 26, 2025 | — |
| 4 | FORM 4 | 0001437749-25-021366 | Jun 26, 2025 | — |
| 4 | FORM 4 | 0001437749-25-021365 | Jun 26, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-021343 | Jun 26, 2025 | — |
| EFFECT | — | 9999999995-25-001732 | May 23, 2025 | — |